Mr. Saad Salman (PhD Scholar GCU, Faisalabad)


Mr. Saad Salman had worked in Academic, Marketing and Hospital settings. He taught Undergraduate and Postgraduate students from the last seven years. He is a Certified Health Researcher from NIH, USA. He has published over twenty-one international publications, two international books, four book chapters and seventeen conference papers/abstracts. He had received numerous awards at various conferences. He is a registered pharmacist and an active member of the American Pharmacist Association and American Society of Consultant Pharmacists.

PhD Scholar Pharmaceutics Department of Pharmaceutics, Government College University Faisalabad, Pakistan
MPhil Pharmacy Department of Pharmacy, Abasyn University, Peshawar, Pakistan 2016
Pharm.D. Pharmaceutical Sciences Department of Pharmacy, University of Peshawar 2014
Lecturer Capital University of Science and Technology (CUST), Islamabad Since – September 2021
Lecturer Department of Pharmacy, The University of Lahore (Islamabad Campus). September 2016 – August 2021
Research Assistant Lady Reading Hospital (Pediatric ward) – [Part time] June 2012 – March 2013
MPhil Coordinator Department of Pharmacy, The University of Lahore (Islamabad Campus) September 2019 – August 2021
Admission Officer The University of Lahore (Islamabad) August 2017 – September 2017
Field Marketing Officer Bayer Healthcare Pvt Ltd May 2014 – September 2016
Internee Lady Reading Hospital (Medical-A ward) April 2013 – June 2013
Clerkship Internee Lady Reading Hospital (Psychiatry ward) May 2012- July 2012
Member Khyber Pakhtunkhwa Pharmacy Council, Peshawar, Pakistan
Member Pakistan Pharmacist Association
  1. Pharmaceutics
  2. Computational techniques
  3. Pharmacy Practice
1. MPhil Physicochemical properties and molecular insights to Favipiravir and Roflumelast bilayer tablet for COVID-19 treatment.
2. MPhil Virtual screening of non-steroidal anti-inflammatory drugs against SARS-CoV2.
3. MPhil Facile green synthesis, proliferation/cytotoxicity and anti-influenza activity of silver nanoparticles.
4. MPhil Method development and validation of nine drugs through experimental analysis backed by artificial intelligence.
5. MPhil Formulation development of Ramelteon oro-dispersible tablet through SeDeM-ODT Expert System and its in-vitro evaluation.
6. MPhil In-vivo and in-silico study of herbal supplements for the treatment of seizures and pain.
1. F.H. Shah, S. Salman, S.T.A Shah, J. Idrees, F. Idrees, A.A. Khan, and B. Ahmad. “Current progress of medicinal plants in Glioblastoma Therapy”, Current Medical Science, vol. 40, no. 6, pp. 1067-1074, 2021.
2. S. Salman, F.H. Shah, J. Idrees, F. Idrees, S. Velagala, J. Ali, and A.A. Khan. “Virtual screening of immunomodulatory medicinal compounds as promising anti-SARS-CoV2 inhibitors”, Future Virology, vol. 5, no. 15, pp. 267-275, 2020.
3. S. Salman, F.H. Shah, M. Chaudry, M. Tariq, and M.Y. Akbar. “In-silico analysis of protein/peptide-based inhalers against SARS-CoV-2”, Future Virology, vol. 15, no. 9, pp. 557-564, 2020.
4. S. Salman, S. Asghar, I.U. Khan, S.H. Khalid, F.H. Shah, and M. Usman. “Equilibrium, Kinetics, Thermodynamics, and Docking studies of Cu2+ ion adsorption over Ion-exchange resins: IRP69H, DC20H, DMSCH, and Kappa carrageenan blends in blood samples”, Pakistan Journal of Pharmaceutical Sciences, vol. 33, no. 2, pp. 795-803, 2020.
5. F.H. Shah, S.T.A. Shah, S. Salman, J. Idrees, F. Idrees, and A. A. Khan. “Therapeutic approaches of prominent medicinal plants for targetting Alzheimer’s disease”, Z Arznei- Gewurzpfla, vol. 24, no. 1, pp. 15–18, 2020.
6. M.U. Khan, A. Ahmad, S. Salman, M. Ayub, T. Aqeel, N. Haq, and F. Saleem. “Muslim scholars’ knowledge, attitudes and perceived barriers towards polio immunization in Pakistan”, Journal of Religion and Health, vol. 56, no. 2, pp. 635-648, 2017.
7. S. Salman, F. Idrees, S. Pervaiz, F.H. Shah, S. Badshah, M. Usman, and S.A. Halimi. “Evaluation of antimicrobial activities of Harmine, Harmaline, Nicotine and their complexes”, Pakistan Journal of Pharmaceutical Sciences, vol. 29, no. 4, pp. 1317-1320, 2016.
8. M.U. Khan, A. Ahmad, T. Aqeel, S. Salman, Q. Ibrahim, and J. Idrees. “Knowledge, attitudes and perceptions towards polio immunization among residents of two highly affected regions of Pakistan”, BMC Public Health, vol. 15, no. 1100, pp 1-8, 2015.
9. M.U. Khan, M. Akram, T. Aqeel, and S. Salman. “A Cross-Sectional Survey of Healthcare Workers on the Knowledge and Attitudes towards Polio Vaccination in Pakistan”, Plos ONE, vol. 10, no. 11, pp. 1-13, 2015.
10. M.I. Zaidi, F.H. Wattoo, M.H.S. Wattoo, S.A. Tirmizi, and S. Salman. “Antibacterial activities of nicotine and its zinc complex”, African Journal of Microbiology Research, vol. 6, no. 24, pp. 5134-5137, 2012.
1. Axonal injury and mitochondrial damage in sodium channel disorders: a genetic variant analysis
2. Therapeutic drug targets: gene editing and CRISPR-9.
3. Intrinsic factors and principles of drug delivery and design.
4. Synthesis and characterization of cadmium sulphide and zinc doped cadmium sulphide quantum dots.
5. Preparation, characterization, & rheology of alprazolam hydrogels with carrageenan blends.
6. Rheology, density functional theory & other parameters for studying the polymer-drug interaction of bromazepam & carrageenan
7. Tobacco utilization in pregnant COPD adolescents: data analysis of 54 countries.
8. Substance use disorder, lung cancer and COPD.
9. Suicide attempts and non-suicidal self-injury among depressed copd patients co-morbid to lung cancer patients: a nationwide longitudinal study of Pakistan and Afghanistan.
10. Fe+2 ions biosorption on xanthium strumarium extracted activated carbon.
11. Suicidality in depressed patients with ADHD: a nationwide longitudinal study.
12. Painless and painful sodium channelopathies: a need for devising new therapeutic targets.
13. Association of Attention Deficit Hyperactivity Disorder with prescription drug abuse.
14. Kinetics, equilibrium and thermodynamic studies of methylphenidate and guanfacine adsorption over activated carbon.
15. Early palliative care for patients with metastatic non-small-cell lung cancer in Khyber Pakhtunkhwa.

Other Members